Clinical Trials Logo
  1. Home
  2. Adolescent Depression
  3. NCT02017535

An Adaptive Treatment Strategy for Adolescent Depression-Continuation — PTAD GIA  

Adolescent Depression Clinical Trial

Official title:
A Personalized Approach to Achieving a Sustained Response to Treatment for Adolescent Depression

Clinical Trial Summary

Aim 1: Assess the feasibility and acceptability of the personalized continuation treatment strategy.

Aim 2: Estimate variances of primary and secondary outcomes with the continuation treatment.

Aim 3: Conduct exploratory hypothesis-generating analyses to inform further development of the personalized continuation treatment strategy to be tested in a subsequent R01 proposal.

Clinical Trial Description

Male and female adolescents (ages 12-18) will be eligible for the study if they completed acute phase treatment and showed at least a partial response to treatment (CGI-I of minimally improved or better (CGI-I < 3)). Adolescents will enter continuation treatment having either received 12 sessions of IPT-A, 16 sessions of IPT-A, or 12 sessions of IPT-A plus fluoxetine.This is a continuation of the study "An Adaptive Treatment Strategy for Adolescent Depression (PTAD)" NCT01802437 ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02017535
Study type Interventional
Source University of Minnesota
Contact
Status Completed
Phase Phase 1/Phase 2
Start date June 2012
Completion date October 1, 2018
View Details
See also
  Status Clinical Trial Phase
Completed NCT00399776 - Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy N/A
Completed NCT04603053 - Determining Effectiveness of an mHealth Intervention to Provide Adolescent CBT N/A
Completed NCT01802437 - An Adaptive Treatment Strategy for Adolescent Depression Phase 1/Phase 2
Completed NCT06325605 - Efficacy and Safety of Bifidobacterium Combined With High-frequency Transcranial Magnetic Stimulation in the Treatment of Adolescent Depression N/A
Completed NCT03154008 - Predictors of Response to Treatment for Depression N/A
Recruiting NCT04613453 - Reducing Adolescent Suicide Risk: Safety, Efficacy, and Connectome Phenotypes of Intravenous Ketamine Phase 2
Terminated NCT00284791 - Lamotrigine in Treatment Resistant Depression in Adolescents N/A
Completed NCT00312897 - Omega-3 Fatty Acids in Adolescent Depression Phase 2
Recruiting NCT01857518 - Depression in Adolescents. A Cerebral Structural, Diffusion, and Functional Magnetic Resonance Imaging Study N/A
Recruiting NCT06072677 - Adolescent Mood During Puberty and Testosterone N/A
Recruiting NCT01170520 - Repetitive Transcranial Stimulation (rTMS) for Resistant Depression in Adolescents Phase 1/Phase 2